{"DataElement":{"publicId":"61396","version":"3","preferredName":"Prior Cancer Diagnosis Ind-3","preferredDefinition":"the yes/no indicator to identify patient/participants who were diagnosed with another cancer prior to study entry.","longName":"PRIOR_CA_DX_IND-3","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010134","version":"4","preferredName":"Prior Cancer Diagnosis","preferredDefinition":"information related to a prior cancer diagnosis.","longName":"PRIOR_CA_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206692","version":"1","preferredName":"Prior Malignant Neoplasm","preferredDefinition":"Earlier in time or order.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25629:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-003B-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E67BAAB3-1B9E-4FCD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-15","modifiedBy":"GDEEN","dateModified":"2023-05-04","changeDescription":"3/2/22 jk added RS.  --- ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812581","version":"1","longName":"DC_0205","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"},{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"2931931","version":"1","longName":"Iloprost Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2931952","version":"1","longName":"Iloprost 12079","context":"SPOREs"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000593","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104908","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"10000594","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104879","version":"1","longName":"GOG-0219","context":"NRG"},{"publicId":"4104888","version":"1","longName":"GOG-0209","context":"NRG"},{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"},{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4171063","version":"1","longName":"RTOG-0534","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4171061","version":"1","longName":"RTOG-1010","context":"NRG"},{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"},{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4104910","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"10000080","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"10000079","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"4171062","version":"1","longName":"RTOG-1005","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"},{"publicId":"4058120","version":"1","longName":"GOG-0278","context":"NRG"},{"publicId":"4104996","version":"1","longName":"GOG-0279","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104901","version":"1","longName":"GOG-0286B","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104898","version":"1","longName":"GOG-0258","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"4104900","version":"1","longName":"GOG-0277","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"},{"publicId":"4104995","version":"1","longName":"GOG-0269","context":"NRG"},{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"},{"publicId":"10000590","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"10000589","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"4104914","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736424","version":"1","longName":"Lung Clinical Data Entry","context":"BBRB"},{"publicId":"6736419","version":"1","longName":"Colon Clinical Data Entry","context":"BBRB"},{"publicId":"6736428","version":"1","longName":"Ovary Clinical Data Entry","context":"BBRB"},{"publicId":"6736422","version":"1","longName":"Kidney Clinical Data Entry","context":"BBRB"}]},{"publicId":"5655939","version":"1","longName":"BLGSP (Burkitt Lymphoma Genome Sequencing Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000269","version":"1","longName":"Enrollment Form","context":"OCG"}]},{"publicId":"5655968","version":"1","longName":"HTMCP (HIV+Tumor Molecular Characterization Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000067","version":"1","longName":"HTMCP","context":"OCG"}]},{"publicId":"6147165","version":"1","longName":"Wake Forest Baptist Medical Center","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6147167","version":"1","longName":"WFB","context":"NCIP"}]}],"AlternateNames":[{"name":"PRIOR_CA_DX_IND-3","type":"USED_BY","context":"SPOREs"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"PRIOR_CA_DX_IND_3","type":"DCP Alt Name","context":"DCP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PRIOR_CA_DX_IND-3","type":"USED_BY","context":"Alliance"},{"name":"PRIOR_CA_DX_IND-3","type":"USED_BY","context":"NRG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"BBRB","type":"USED_BY","context":"BBRB"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"IE_IEORRES_PRIORDX","type":"OID, CCTG","context":"CCTG"},{"name":"EC115ACNDX","type":"OID, AMC","context":"AMC"},{"name":"EC115BCNDX","type":"OID, AMC","context":"AMC"},{"name":"CHSGE1CAN","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Has the patient had any prior","type":"Preferred Question Text","description":"Has the patient had any prior cancer diagnosed?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"History of Prior Malignancy","url":null,"context":"CTEP"},{"name":"DCP Document Text","type":"Alternate Question Text","description":"History of a prior 5mm or carcinoma within five years?","url":null,"context":"DCP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Has the patient had a prior malignancy within the past 5 years","url":null,"context":"CTEP"},{"name":"DCP Document Text 2","type":"Alternate Question Text","description":"History of prior adenoma or carcinoma within six years?","url":null,"context":"DCP"},{"name":"History of Prior Malignancy","type":"Alternate Question Text","description":"History of Prior Malignancy (If yes, this is an exclusion criterion)","url":null,"context":"NCIP"},{"name":" Has this patient at any time in their life had a prior diagnosis of a malignant neoplasm","type":"Alternate Question Text","description":"Has this patient at any time in their life had a prior diagnosis of a malignant neoplasm","url":null,"context":"NCIP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Has the patient had any (other) prior cancer diagnosed?","url":null,"context":"CTEP"},{"name":"CRF Text 4","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except non-melanomatous skin cancer) within the last 3 years?","url":null,"context":"NRG"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Has the patient had any other cancer(s) prior to this lung cancer, including previous lung cancer?","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Has the patient had a prior invasive solid tumor or hematological malignancy (except non-melanomatous skin cancer or incidentally discovered prostate cancer at the time of cystoprostatectomy) unless disease free for a minimum of 3 years?","url":null,"context":"NRG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Was patient previously diagnosed with a different type of cancer?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Does patient have prior history of malignancy?","url":null,"context":"CTEP"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Did patient have a cancer diagnosis < 21 years of age, irrespective of current age?","url":null,"context":"CTEP"},{"name":"BPV - Does the participant have a history of prior malignancy","type":"Alternate Question Text","description":"Does the participant have a history of prior malignancy","url":null,"context":"BBRB"},{"name":"NRG_CRF_Text7","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except non-melanomatous skin cancer) within the last 1 year?","url":null,"context":"NRG"},{"name":"NRG CRF_Text6","type":"Alternate Question Text","description":"Has the patient had any prior cancer diagnosed other than cervical cancer?","url":null,"context":"NRG"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Cancer other than your current breast cancer","url":null,"context":"Alliance"},{"name":"CRF_TEXT","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy, excluding current diagnosis and/or non-melanomatous skin cancer,within  the last 2 years?","url":null,"context":"NRG"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Has the patient had a prior malignancy (excluding the current diagnosis and/or non-melanomatous skin cancer) within the past 3 years","url":null,"context":"NRG"},{"name":"EA1151 EC","type":"Alternate Question Text","description":"Has the patient ever been diagnosed with ovarian, endometrial, or other cancer?","url":null,"context":"ECOG-ACRIN"},{"name":"NRG CRF_Text 9","type":"Alternate Question Text","description":"Does the patient have a history of another primary malignancy, with the exception of the malignancies listed in section 3.3.5?","url":null,"context":"NRG"},{"name":"NRG CRF_Text 8","type":"Alternate Question Text","description":"Does the patient have a history of another primary malignancy, with the exception of a) Curatively treated non-melanomatous skin cancer; b) curatively treated cervical carcinoma in situ;  c) non-metastatic prostate cancer;  d) other primary non-hematologic malignancies or solid tumor treated with curative intent, no known active disease, and no treatment administered during the last 3 years prior to registration","url":null,"context":"NRG"},{"name":"NRG CRF_Text 10","type":"Alternate Question Text","description":"Prior or current invasive malignancy with current evidence of active disease within the past 3 years","url":null,"context":"NRG"},{"name":"NRG CRF_Text 12","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except non-melanomatous skin cancer and early stage treated prostate cancer) within the last 3 years?","url":null,"context":"NRG"},{"name":"NRG CRF_Text 11","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except non-melanomatous skin cancer and malignancies listed in section 3.3.2 within the last 2 years?","url":null,"context":"NRG"},{"name":"CRF Text 9","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (except non-melanomatous skin cancer)?","url":null,"context":"CTEP"},{"name":"NRG_CRF_TEXT13","type":"Alternate Question Text","description":"Has the patient had an active malignancy within the last 2 years (other than the study cancer or the allowable cancers listed in 3.3 of the protocol)?","url":null,"context":"NRG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Did patient have a cancer diagnosis < 22 years of age, irrespective of current age?","url":null,"context":"COG"},{"name":"NRG_CRF_Text 14","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (other than those allowed per section 3.3 of the protocol) within the last 3 years?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text 15","type":"Alternate Question Text","description":"Has the patient had an active malignancy within the last 2 years that may alter the course of prostate cancer treatment?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text 18","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (other than those allowed per section 3.3 of the protocol) within the last 2 years?","url":null,"context":"NRG"},{"name":"CRF text20","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignancy (other than keratinocyte carcinoma or carcinoma in situ) whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen with no evidence of disease for more than 3 years?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text19","type":"Alternate Question Text","description":"Has the patient had an active malignancy within the last 3 years (other than the study cancer or the allowable cancers listed in 3.2 of the protocol)?","url":null,"context":"NRG"},{"name":"NRG_CRF TEXT 21","type":"Alternate Question Text","description":"Has the patient had a prior non-head and neck invasive malignancy (except non-melanomatous skin cancer, including effectively treated basal cell or squamous cell skin cancer) unless disease free for 2 or more years?","url":null,"context":"NRG"},{"name":"WF1805CD","type":"Alternate Question Text","description":"History of any other cancer, other than non-melanoma skin disease.","url":null,"context":"NCIP"},{"name":"NRG_CRF TEXT 20","type":"Alternate Question Text","description":"Has the patient had a prior non-head and neck invasive malignancy (except non-melanomatous skin cancer, including effectively treated basal cell or squamous cell skin cancer) unless disease free for ≥ 2 calendar years?","url":null,"context":"NRG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Has the patient had a prior history of malignancy (except desmoid tumor(s) and non-melanomatous skin cancer) that are not in remission for more than 3 years?","url":null,"context":"COG"},{"name":"NRG-CRF_TEXT 22","type":"Alternate Question Text","description":"Has the patient had a prior or current invasive malignancy (other than those allowed per section 3.3 of the protocol) with current evidence of active disease within the last 2 years?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_24","type":"Alternate Question Text","description":"Has the patient had an active malignancy within the last 5 years (other than the study cancer or the allowable cancers listed in 3.2 of the protocol)?","url":null,"context":"NRG"},{"name":"CRF Text 21","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignancy?","url":null,"context":"CTEP"},{"name":"NRG_CRF_TEXT 23","type":"Alternate Question Text","description":"Does the patient have a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen?","url":null,"context":"NRG"},{"name":"COG CRF TExt 6","type":"Alternate Question Text","description":"Did patient have previous cancer that required systemic chemotherapy and/or thoracic radiation?","url":null,"context":"COG"},{"name":"CRF Text 22","type":"Alternate Question Text","description":"History of another primary malignancy except for malignancy treated with curative intent with no known active disease for greater than or equal to 2 years, and adequately treated non-melanomatous skin cancer or carcinoma in situ (e.g. cervical CIS) without evidence of disease","url":null,"context":"Alliance"},{"name":"COG CRF Text 101","type":"Alternate Question Text","description":"Did patient have previous cancer that required systemic chemotherapy and/or thoracic radiation and has not been in remission for three years?","url":null,"context":"COG"},{"name":"COG CRF Text 102","type":"Alternate Question Text","description":"Did patient have previous cancer that required systemic chemotherapy and/or thoracic radiation and has not been in remission for three years?","url":null,"context":"COG"},{"name":"NRG_CRF_20","type":"Alternate Question Text","description":"Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years (a history or current diagnosis of hematologic malignancy is not allowed)","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_25","type":"Alternate Question Text","description":"Has the patient had a prior metastatic or non-metastatic,  invasive malignancy (except non metastatic,non-melanomatous skin cancer) unless continuously disease free for greater than or equal to 3 years?","url":null,"context":"NRG"},{"name":"Evidence of a prior cancer (excluding non-melanoma skin cancer) within 3 years of the designated clinician visit.","type":"Alternate Question Text","description":"Evidence of a prior cancer (excluding non-melanoma skin cancer) within 3 years of the designated clinician visit.","url":null,"context":"NCIP"},{"name":"CRF Text#5","type":"Alternate Question Text","description":"Does the patient have a history of prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen on this trial?","url":null,"context":"ECOG-ACRIN"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"Does the patient have a history of prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen on this trial?","url":null,"context":"NRG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Patient has had previous head and neck cancer or multiple synchronous primary head and neck cancers.","url":null,"context":"CCTG"},{"name":"NRG_CRF_Text_26","type":"Alternate Question Text","description":"Does the patient have a concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessments of the investigational regimen?","url":null,"context":"NRG"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"Has the participant been diagnosed with or treated for cancer within the last 5 years?","url":null,"context":"AMC"},{"name":"AMC CRF Text 2","type":"Alternate Question Text","description":"Does the participant have a current or prior (within the last 5 years) diagnosis of cancer that meets one of the three qualifying categories?","url":null,"context":"AMC"},{"name":"AMC CRF Text 3","type":"Alternate Question Text","description":"Has the participant had more than 1 prior cancer within 5 years? Do not report the cancer that qualified the participant for study participation","url":null,"context":"AMC"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Does patient have a history of prior cancers other than ALL or AML?","url":null,"context":"COG"},{"name":"NRG_CRF_Text_27","type":"Alternate Question Text","description":"Has the patient had a prior invasive malignancy (other than those allowed per section 3.2 of the protocol) within the last 3 years?","url":null,"context":"NRG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Does patient have a history of any cancer(s) other than ALL or AML?","url":null,"context":"COG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Prior hematologic or invasive solid tumor malignancy (except non-melanomatous skin cancer) unless disease and treatment free for a minimum of 3 years.","url":null,"context":"NRG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Does the participant have a first time diagnosis of non-metastatic breast cancer which is Stage I-III?","url":null,"context":"NRG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Was patient previously diagnosed with another cancer other than the one enrolled for this study?","url":null,"context":"COG"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B99FA18D-0E89-3BC1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-24","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-03-24","modifiedBy":"KUMMEROA","dateModified":"2023-09-06","changeDescription":"Replaced VD Diagnosis Ind-3 (2018439v1) with VD Yes No Unknown Indicator (3506034v1) - dbw","administrativeNotes":"2023.9.6 AQT added per ticket request CADSR0002816. ak 2023.4.11 AQT added per ticket request CADSR0002295. ak 2/14/23 added AQT for NRG ticket request CADSR0002048 cjl; 11/18/22 added AQT for NRG ticket request CADSR0001716 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}